1. Home
  2. EVER vs NRIX Comparison

EVER vs NRIX Comparison

Compare EVER & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVER
  • NRIX
  • Stock Information
  • Founded
  • EVER 2008
  • NRIX 2009
  • Country
  • EVER United States
  • NRIX United States
  • Employees
  • EVER N/A
  • NRIX N/A
  • Industry
  • EVER Computer Software: Programming Data Processing
  • NRIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVER Technology
  • NRIX Health Care
  • Exchange
  • EVER Nasdaq
  • NRIX Nasdaq
  • Market Cap
  • EVER 960.3M
  • NRIX 1.1B
  • IPO Year
  • EVER 2018
  • NRIX 2020
  • Fundamental
  • Price
  • EVER $22.70
  • NRIX $10.24
  • Analyst Decision
  • EVER Strong Buy
  • NRIX Strong Buy
  • Analyst Count
  • EVER 6
  • NRIX 18
  • Target Price
  • EVER $32.33
  • NRIX $30.39
  • AVG Volume (30 Days)
  • EVER 688.7K
  • NRIX 1.2M
  • Earning Date
  • EVER 05-05-2025
  • NRIX 04-08-2025
  • Dividend Yield
  • EVER N/A
  • NRIX N/A
  • EPS Growth
  • EVER N/A
  • NRIX N/A
  • EPS
  • EVER 0.88
  • NRIX N/A
  • Revenue
  • EVER $500,190,000.00
  • NRIX $56,417,000.00
  • Revenue This Year
  • EVER $27.51
  • NRIX $12.84
  • Revenue Next Year
  • EVER $11.88
  • NRIX N/A
  • P/E Ratio
  • EVER $25.73
  • NRIX N/A
  • Revenue Growth
  • EVER 73.72
  • NRIX N/A
  • 52 Week Low
  • EVER $16.63
  • NRIX $8.18
  • 52 Week High
  • EVER $30.03
  • NRIX $29.56
  • Technical
  • Relative Strength Index (RSI)
  • EVER 42.77
  • NRIX 39.72
  • Support Level
  • EVER $19.70
  • NRIX $9.23
  • Resistance Level
  • EVER $22.98
  • NRIX $10.17
  • Average True Range (ATR)
  • EVER 1.54
  • NRIX 1.04
  • MACD
  • EVER -0.34
  • NRIX 0.15
  • Stochastic Oscillator
  • EVER 31.71
  • NRIX 53.51

About EVER EverQuote Inc.

EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Share on Social Networks: